December 12, 2024 16:38 (IST)
AIIMS Delhi to start screening 6-12 yrs children for Covaxin trial from Tuesday
Jun 15, 2021, at 05:57 am
New Delhi/IBNS: The All India Institute of Medical Sciences (AIIMS), New Delhi will begin the selection process of children in the age group of 6-12 years for the clinical trials of Bharat Biotech's Covaxin on Tuesday, said Dr Sanjay Rai, professor at the Centre for Community Medicine at AIIMS Delhi, said a media report.
Latest Headlines